Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.
D005492:Folic Acid / Q000031:analogs & derivatives; D005493:Folic Acid Antagonists / Q000628:therapy*; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology*; D007261:Infusions, Intra-Arterial; D002955:Leucovorin; D008727:Methotrexate; D009055:Mouth / Q000494:pharmacology*; D009092:Mucous Membrane; D009369:Neoplasms; D010614:Pharynx / Q000494:pharmacology*
D005493:Folic Acid Antagonists; D005492:Folic Acid; D006821:Hyaluronoglucosaminidase; D002955:Leucovorin; D008727:Methotrexate
FOLIC ACID ANTAGONISTS/therapy; FOLIC ACID/related compounds; HYALURONIDASE/pharmacology; MOUTH/pharmacology; PHARYNX/pharmacology